The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Semigolovskiĭ N.Iu.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Vertsinskiĭ E.K.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Azanov B.A.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Ivanova E.V.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Positive inotropic properties of levocarnitine in low ejection syndrome among patients wiht acute myocardial infarction

Authors:

Semigolovskiĭ N.Iu., Vertsinskiĭ E.K., Azanov B.A., Ivanova E.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(3): 43‑46

Read: 4572 times

Download PDF (RU)
Contact the author
Table of contents

POSITIVE INOTROPIC PROPERTIES OF LEVOCARNITINE IN LOW EJECTION SYNDROME AMONG PATIENTS WIHT ACUTE MYOCARDIAL INFARCTION
POSITIVE INOTROPIC PROPERTIES OF LEVOCARNITINE IN LOW EJECTION SYNDROME AMONG PATIENTS WIHT ACUTE MYOCARDIAL INFARCTION

To cite this article:

Semigolovskiĭ NIu, Vertsinskiĭ EK, Azanov BA, Ivanova EV. Positive inotropic properties of levocarnitine in low ejection syndrome among patients wiht acute myocardial infarction. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(3):43‑46. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Abstract:

Keywords:

acute myocardial infarction
low ejection syndrome
levocarnitine

Authors:

Semigolovskiĭ N.Iu.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Vertsinskiĭ E.K.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Azanov B.A.

FGBUZ "Klinicheskaia bol'nitsa #122 im. L.G. Sokolova" FMBA RF, Sankt-Peterburg

Ivanova E.V.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Close metadata

References:

  1. Astashkin E.I., Glezer M.G. Rol' L-karnitina v energeticheskom obmene kardiomiotsitov i lechenii zabolevanii serdechno-sosudistoi sistemy. Kardiologiya i serdechno-sosud khir 2012; 2: 58-65.
  2. Leont'eva I.V., Sukhorukov V.S. Znachenie metabolicheskikh narushenii v geneze kardiomiopatii i vozmozhnosti primeneniya L-karnitina dlya terapevticheskoi korrektsii. Vestn pediatr farmakol i nutritsiol 2006; 2: 12-14.
  3. Semigolovskii N.Yu., Vertsinskii E.K., Azanov B.A. i dr. Pervyi klinicheskii opyt primeneniya infuzionnogo otechestvennogo preparata levokarnitina pri sindrome malogo vybrosa u bol'nykh infarktom miokarda, tromboemboliei legochnoi arterii i dilatatsionnoi kardiomiopatiei. S''ezd assotsiatsii anesteziologov-reanimatologov Severo-Zapada Rossii, 6-i: Materialy. Efferentnaya ter 2011; 3: 136-137.
  4. Semigolovskii N.Yu., Vertsinskii E.K., Azanov B.A. i dr. Opyt primeneniya infuzionnogo otechestvennogo preparata levokarnitina pri sindrome malogo vybrosa u bol'nykh ostrym infarktom miokarda. Byul NTsSSKh im. A.N. Bakuleva RAMN 2012; 3: 69.
  5. Semigolovskii N.Yu., Vertsinskii E.K., Azanov B.A., Sborshchikova A.K. Polozhitel'nye inotropnye svoistva infuzionnogo otechestvennogo preparata levokarnitina u bol'nykh ostrym infarktom miokarda. Mezhdunarodnaya nauchno-prakticheskaya konferentsiya "Vnezapnaya smert': ot otsenki riska k profilaktike", 8-ya: Tezisy. Byul Federal'nogo tsentra serdtsa, krovi i endokrinologii im. V.A. Almazova 2012; 2: 21-22 (prilozhenie 2).
  6. Arsenian M.A. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 1997; 40: 3: 265-286.
  7. Bartels G.L., Remme W.J., Pillay M. et al. Effects of L-propionylcamitine on ischemia-induced myocardial dysfunction in men with angina pectoris. Am J Cardiol 1994; 74: 2: 125-130.
  8. Cacciatore L., Cerio R., Ciarimboli M. et al. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study. Drugs Exp Clin Res 1991; 17: 4: 225-235.
  9. Canale C., Terrachini V., Biagini A. et al. Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: Semiautomatic computerized analysis of M-mode tracings. Int J Clin Pharmacol Ther Toxicol 1988; 26: 4: 221-224.
  10. Cherchi A. Effects of L-carnitine on exercise tolerance in chronicstable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol 1985; 23: 10: 569-572.
  11. Cherchi A., Lai C., Onnis E. et al. Propionylcarnitine in stable effort angina. Cardiovasc Drugs Ther 1990; 4: 2: 581-586.
  12. Davini P., Bigalli A., Lamanna F., Boem A. Controlled study on L-carnitine therapeutic efficacy in post infarction. Drug Exp Clin Res 1992; 18: 8: 355-365.
  13. Dinicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH. L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. Mayo Clin Proc. 2013 Apr 15: 1-8
  14. Ferrari R., Socchini F., Di Lisa F. et al. The effect of L-carnitine on myocardial metabolism of patients with coronary artery disease. Olin Trials J 1984; 21: 40-58.
  15. Ferrari R., Merli E., Cicchitelli G. et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci 2004; 1033: 79-91.
  16. Fujiwara M., Nakano T., Tamoto S. et al. Effect of L-carnitine in patients with ischemie hear disease. J Cardiol 1991; 21: 493-504.
  17. Helton E., Darragh R., Francis P. et al. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy. Pediatrics 2001; 105: 1260-1270.
  18. Iliceto S., Scrutinio D., Bruzzi P. et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-sarnitine ecocardiografia digitalizzata infarto miocardico (CEDIM) Trial. JACC 1995; 26: 2: 380-387.
  19. Kamikawa T., Suzuki Y., Kobayashi A. et al. Effect of L-carnitine on exercise tolerance in patients with stable angina pectoris. Jpn Heart J 1984; 25: 587-597.
  20. Kobayashi A., Masamura Y., Yamazaki N. L-Carnitine treatment for chronic heart failure - experimental and clinical study. Jpn Cire J 1992; 56: 86-94.
  21. Lango R., Smolenski R., Narkiewicz M. et al. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res 2001; 51: 21-29.
  22. Opie L.H. Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 1979; 97: 375-388.
  23. Rahbar A., Shakerhosseini R., Saadat N. et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005; 59: 4: 592-596.
  24. Rebouche C.J., Engel A.G. Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 1983; 58: 533-540.
  25. Rebuzzi A.G., Schiavoni G., Amico C.M. et al. Beneficial effect of L-carnitine in the reduction of necrotic area in acute myocardial infarction. Drugs Exp Clin Res 1984; 10: 219-223.
  26. Regitz V., Shug A.L., Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular hear diseases. Am J Cardiol 1990; 65: 755-760.
  27. Rizzon P., Biaseo G., Boscia F. et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Hear J 1989; 10: 502-508.
  28. Shag A.L., Thomsen J.H., Folts J.D. et al. Changes in tissue levels of carnitine and other metabolites during isehaemia and anoxia. Arch Biochem Biophys 1978; 187: 25.
  29. Singh R.B., Niaz M.A., Agarwal P. et al. A randomized, double-blind, placebo controlled trial of L-carnitine in suspected myocardial infarction. Postgrad Med J 1996; 72: 843: 45-50.
  30. Spagnoli L.G., Corsi M., Villaschi S. et al. Myocardial carnitine deficiency in acute myocardial infarction. Lancet 1982; i: 1419-1420.
  31. Suzuki Y., Masumura Y., Kobayashi A. et al. Myocardial carnitine deficiency in chronic heart failure. Lancet 1982; 1: 116.
  32. Suzuki Y., Kawikawa T., Kobayashi A. et al. Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts. Jpn Circ J 1981; 45: 687-694.
  33. Tarantini G., Scrutinio D., Bruzzi P. et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology 2006; 106: 4: 215-223.
  34. Thomsen J.H., Shug A.L. Yap V.U. et al. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol 1979; 43: 300-306.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.